Multiple Sclerosis Severity ScoreRichard Roxburgh, D. A. S. Compston, Shaun R. Seaman et al.|Neurology|2005Cited by 957
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialGıancarlo Comı, Massimo Filippi, Vittorio Martinelli et al.|The Lancet|2009Cited by 587
A High-Density Screen for Linkage in Multiple SclerosisStephen Sawcer, Jonathan L. Haines, Maria Ban et al.|The American Journal of Human Genetics|2005Cited by 295
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple SclerosisTim Spelman, Jan Lycke, Melinda Magyari et al.|JAMA Neurology|2021Cited by 237
Treatment decisions in multiple sclerosis — insights from real-world observational studiesMaría Trojano, Helmut Butzkueven, Mar Tintoré et al.|Nature Reviews Neurology|2017Cited by 191